Patents by Inventor Evgeny Danilovich Goldberg

Evgeny Danilovich Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140010819
    Abstract: The present application relates to the use of an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to cytokines implicated in the course of inflammation, including autoimmune inflammation, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to the homeopathic technology.
    Type: Application
    Filed: September 9, 2013
    Publication date: January 9, 2014
    Inventors: Oleg Iliich Epshtein, Evgeny Danilovich Goldberg, Alexandr Mikhailovich Dygay
  • Patent number: 7923009
    Abstract: A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to homeopathic technology. In order to obtain the antibodies, the prostate-specific antigen isolated from the prostatic tissues of cattle or prepared synthetically is employed; a mixture of various, mostly centesimal, homeopathic dilutions is used. The method of treating diseases of the urogenital sphere consists in using activated forms of ultra-low doses of antibodies to prostate-specific antigen prepared by multiple consecutive dilutions and exposure to external factors.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: April 12, 2011
    Inventors: Oleg Iliich Epshtein, Evgeny Danilovich Goldberg, Alexandr Mikhailovich Dygay
  • Patent number: 7700096
    Abstract: A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to endothelial nitric oxide synthase (NO synthase), the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to the homeopathic technology. A method of treating erectile dysfunctions and vegetative disturbances of male climax by regulating the level of cyclic guanosine monophosphate (cGMP) in the cavernous bodies on sexual stimulation, the method being characterized by the use of activated forms of ultra-low doses of antibodies to the entire molecule of the endothelial NO synthase or to its polypeptide fragments, activated forms being prepared by multiple consecutive dilutions and exposure to external factors.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: April 20, 2010
    Inventors: Oleg Iliich Epshtein, Evgeny Danilovich Goldberg, Alexandr Mikhailovich Dygay
  • Publication number: 20090285829
    Abstract: A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to homeopathic technology. In order to obtain the antibodies, the prostate-specific antigen isolated from the prostatic tissues of cattle or prepared synthetically is employed; a mixture of various, mostly centesimal, homeopathic dilutions is used. The method of treating diseases of the urogenital sphere consists in using activated forms of ultra-low doses of antibodies to prostate-specific antigen prepared by multiple consecutive dilutions and exposure to external factors.
    Type: Application
    Filed: July 14, 2009
    Publication date: November 19, 2009
    Inventors: Oleg Iliich Epshtein, Evgeny Danilovich Goldberg, Alexandr Mikhailovich Dygay
  • Patent number: 7582294
    Abstract: A medicament based on antibodies contains an activated form of ultra-low doses of monoclonal, polyclonal, or natural antibodies to the prostate-specific antigen, the activated form being prepared by multiple consecutive dilutions and exposure to external factors, preferably according to homeopathic technology. In order to obtain the antibodies, the prostate-specific antigen isolated from the prostatic tissues of cattle or prepared synthetically is employed; a mixture of various, mostly centesimal, homeopathic dilutions is used. The method of treating diseases of the urogenital sphere consists in using activated forms of ultra-low doses of antibodies to prostate-specific antigen prepared by multiple consecutive dilutions and exposure to external factors.
    Type: Grant
    Filed: August 2, 2002
    Date of Patent: September 1, 2009
    Assignee: Oleg Oliich Epshtein
    Inventors: Oleg Iliich Epshtein, Evgeny Danilovich Goldberg, Alexandr Mikhailovich Dygay